CLOVER HEALTH INVESTMENTS, CORP. /DE Segments Disclosure
| Year ended December 31, | ||||||||||||||||||||
| Insurance Segment | 2025 | 2024 | 2023 | |||||||||||||||||
(in thousands) | ||||||||||||||||||||
| Premiums earned, net (net of ceded premiums) | $ | 1,891,732 | $ | 1,344,881 | $ | 1,235,769 | ||||||||||||||
| Less: | ||||||||||||||||||||
| Net medical claims incurred | 1,618,219 | 1,010,289 | 1,003,683 | |||||||||||||||||
Segment gross profit | $ | 273,513 | $ | 334,592 | $ | 232,086 | ||||||||||||||
Reconciliation: | ||||||||||||||||||||
Elimination of intersegment profits (losses) | $ | 49,813 | $ | 3,962 | $ | (907) | ||||||||||||||
| Other income | 32,576 | 26,250 | 24,774 | |||||||||||||||||
Salaries and benefits | (225,475) | (232,454) | (257,157) | |||||||||||||||||
General and administrative expenses | (214,270) | (176,480) | (183,089) | |||||||||||||||||
| Impairment of goodwill and other intangible assets | — | — | (15,945) | |||||||||||||||||
| Premium deficiency reserve benefit | — | — | 7,239 | |||||||||||||||||
| Depreciation and amortization | (1,686) | (1,331) | (2,509) | |||||||||||||||||
| Restructuring costs | — | (288) | (9,821) | |||||||||||||||||
| Change in fair value of warrants | (20) | (50) | (86) | |||||||||||||||||
| Interest expense | — | — | (7) | |||||||||||||||||
Loss on investment | — | (467) | (4,726) | |||||||||||||||||
| Net loss from continuing operations | $ | (85,549) | $ | (46,266) | $ | (210,148) | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 27, 2026 | Showing above |
| 2024 | Mar 3, 2025 | |
| 2023 | Mar 14, 2024 | |
| 2022 | Mar 1, 2023 | |
| 2021 | Feb 28, 2022 | |
About Segments Disclosures
Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.
Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.